Nutrition%20in%20pregnancy Signs and Symptoms

Signs and Symptoms

Introduction

Nutrition is the intake of food necessary for optimal health
- Good nutrition is a well-balanced diet that contains all essential nutrients in optimal amounts while poor nutrition either lacks or has excess nutrients
- Malnutrition (poor nutrition) can result from insufficient intake of macronutrients eg protein and calories (undernutrition) or from insufficient intake or increased losses of vitamins and minerals (micronutrient malnutrition) due to an unbalanced diet
  - Can also result from overconsumption of non-nutritive calories (overnutrition) or underconsumption of nutrient-rich food
Choices regarding maternal nutrition and lifestyle affect maternal and child health
- The World Health Organization (WHO) recommends that women develop healthy dietary behaviors prior, during and after their pregnancy for optimal maternal and infant health outcomes
- A pregnant woman’s dietary behavior can influence the development of fetal organs early in pregnancy and fetal growth and brain development later in pregnancy
The goal of prenatal nutrition is to provide for the optimal development of the fetus and to support maternal health
A healthy pregnancy outcome is brought about by consumption of a healthy and balanced diet with safe food handling, supplementation with the proper vitamins and minerals, appropriate physical activity and weight gain during pregnancy, and avoidance of alcohol and other harmful substances

Management of recurrent implantation failure during the COVID-19 pandemic

Dr. Ameet Patki, Dr. Prakash Mayandi, 22 Mar 2022

Recurrent implantation failure (RIF) refers to the failure to achieve a clinical pregnancy after three in vitro fertilization (IVF) attempts with at least four good-quality embryos. RIF leaves couples frustrated and desperate for answers and is challenging for clinicians to handle, compounded by the impact of the COVID-19 pandemic restrictions. Two experts, Dr Ameet Patki, Medical Director of Fertility Associates Mumbai and Hon Assoc Prof at KJ Somaiya Medical College & Hospital, India, and Dr Prakash Mayandi, Metro IVF Fertility Centre, Kuala Lumpur, Malaysia, weigh in with their views on managing RIF during the COVID-19 pandemic.

Product Highlight - Evenity

01 Dec 2021

Romosozumab 105 mg/1.17 mL soln for inj

The changing treatment landscape for premenopausal women with advanced breast cancer: Focus on ribociclib

Dr. Wong Seng Weng, Dr. Lee Guek Eng, 19 Mar 2021

In Singapore, advanced breast cancer (aBC) is the leading cause of cancer death in women 30–49 years of age. For premenopausal women diagnosed with hormone receptor (HR)-positive, HER2-negative BC, cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors provide new hope. Currently, ribociclib is the only CDK4/6 inhibitor studied in the first-line setting for premenopausal women with HR+/HER2- aBC, in the phase III MONALEESA-7 trial. Two experts, Dr Wong Seng Weng, Medical Director & Consultant Medical Oncologist at The Cancer Centre, Paragon Medical & Mount Elizabeth Novena Specialist Centre, and Dr Lee Guek Eng, Senior Consultant & Specialist in Medical Oncology at Icon Cancer Centre and Program Director of the Young Women Cancer Program, weigh in with their views on managing premenopausal women with aBC.